Quoin Pharma Says FDA Clears Recruitment Of Teen Subjects For Two Ongoing Clinical Trials For QRX003

RTTNews | 542 days ago
Quoin Pharma Says FDA Clears Recruitment Of Teen Subjects For Two Ongoing Clinical Trials For QRX003

(RTTNews) - Quoin Pharmaceuticals Ltd. (QNRX) announced Monday that the U.S. Food and Drug Administration (FDA) has cleared the recruitment of teen subjects aged 14 years and older into its two ongoing clinical trials for QRX003, which is being developed as a potential treatment for Netherton Syndrome (NS).

Both trials are being conducted under Quoin's open Investigational New Drug Application (IND) for QRX003. The clearance includes teen patients in both the company's open label and placebo controlled studies.

This important development represents the first ever inclusion of non-adult subjects in Netherton Syndrome clinical studies conducted under an open Investigational New Drug Application.

read more
Antipodean Currencies Rise As Traders Await U.S. PCE Inflation Data

Antipodean Currencies Rise As Traders Await U.S. PCE Inflation Data

The antipodean currencies such as the Australia and the New Zealand dollars strengthened against their major currencies in the Asian session on Friday, as traders await the July Personal Consumption Expenditures (PCE) price index due later in the day.
RTTNews | 19 minutes ago
Asian Shares Mixed Ahead Of US PCE Inflation Data

Asian Shares Mixed Ahead Of US PCE Inflation Data

Asian stocks ended mixed on Friday as caution prevailed ahead of a key U.S. inflation report due later in the day that might show core personal consumption expenditures prices rose 2.9 percent in July, the fastest pace in five months.
RTTNews | 34 minutes ago
European Shares Seen Mostly Lower Before US Inflation Data

European Shares Seen Mostly Lower Before US Inflation Data

European stocks may open broadly lower on Friday as the prospect of a peace agreement between Russia and Ukraine waned and focus shifted to a key U.S. inflation reading due later in the day that could provide additional clues on the Federal Reserve's rate outlook.
RTTNews | 3h 33min ago
Australian Market Swings To Modest Gains In Mid-market

Australian Market Swings To Modest Gains In Mid-market

The Australian stock market is swinging to modest gains in mid-market moves on Friday after opening in the red, extending the gains in the previous two sessions, following the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is staying below the 9,000 mark, with gains in energy and technology stocks partially offset by weakness in mining and financial stocks.
RTTNews | 5h 37min ago